Personalized Dosing. Simplified Delivery.
Taking medication isn’t always as simple as taking one pill at the same time every day. Some medicines require dose adjustments over time to find the right amount for each patient. In collaboration with Adare, OnDosis® is developing a new approach to oral dosing that provides greater precision and flexibility.
The Dosage Manager is designed to dispense individualized doses from a pre-filled medicine cartridge, helping simplify complex medication regimens. The system is designed for multiparticulate medicines, including granules, pellets and mini-tablets, enabling precise dose adjustments in smaller increments beyond traditional fixed-dose options.
HOW IT WORKS
CONTROL UNIT
A reusable, rechargeable device controls the dispensing of each dose.
MEDICINE CARTRIDGE
A pre-filled cartridge contains the prescribed medicine and is replaced when empty.
DISPENSED DOSE
The selected dose is dispensed into a cup for administration.
OPTIONAL DIGITAL SERVICE
Connected digital tools can provide patients, caregivers and healthcare professionals with treatment and dosing information.
By combining drug delivery technology with a connected device platform, OnDosis® is working to create a more precise, flexible and adaptable approach to oral dosing. The goal is to make complex medication regimens simpler while better accommodating changes in a patient’s treatment.
Speak With An Expert
Nathan Dormer
Director, Drug Product Development
Nathan Dormer, Ph.D., is the Senior Director of Drug Product Development & Site Leader at Adare Pharma Solutions and is responsible for pharmaceutical development activities at Adare’s facilities, supporting a team of formulation scientists and analysts. He is a pharmaceutical scientist and bioengineer by training, with more than 16 years of experience developing microsphere-based solid oral and parenteral/implantable dosage forms in academic, innovator, and CDMO settings. Dr. Dormer earned his B.S. in Chemical Engineering and his Ph.D. (w/Honors) in Bioengineering from The University of Kansas while receiving NIH-sponsored Pharmaceutical Biotech Training.